Browsing Tag
Leber Hereditary Optic Neuropathy
1 post
Can early access to GS010 in Israel accelerate GenSight’s push toward full regulatory approval?
GenSight Biologics secures Israeli early access for GS010 gene therapy in LHON. Find out how this could reshape access, manufacturing, and investor outlook.